A Prospective Multicenter Non-interventional Study to Evaluate User Satisfaction With Estradiol Valerate/ Dienogest in Real Clinical Practice to be Conducted in Russia
Latest Information Update: 27 Jul 2023
At a glance
- Drugs Estradiol valerate/dienogest (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms Q-SWAN
- Sponsors Bayer
Most Recent Events
- 24 Jul 2023 Status changed from recruiting to completed.
- 07 Dec 2022 Planned primary completion date changed from 31 Dec 2022 to 30 Jun 2023.
- 16 Jul 2021 Status changed from not yet recruiting to recruiting.